Pyrocaps Capsule 20 mg Capsules
PDF Leaflet Revision Date: 8 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
For anti-inflammatory and analgesic activity in conditions like rheumatoid arthritis and acute gout.
Dosage (summary)
20mg daily for rheumatoid arthritis; 40mg for 2 days for acute musculoskeletal disorders, then 20mg; 40mg for acute gout.
Onset of Action / Duration
Onset: 7-10 days, Duration: 24 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Not recommended in late pregnancy; may cause fetal renal dysfunction. Safety in lactation not established.
Key Drug Interactions
- Anticoagulants
- Other NSAIDs
- Methotrexate
- Lithium
Contraindications
- Hypersensitivity to piroxicam
- Active peptic ulcer
- Severe heart failure
- Last trimester of pregnancy
Common side effects
- Gastrointestinal bleeding
- Dizziness
- Headache
- Skin rash
Counselling Points
- Take with food to minimize GI upset
- Report any unusual abdominal symptoms
- Avoid use in pregnancy unless advised
Serious warnings
- Risk of serious gastrointestinal events
- Skin reactions like SJS and TEN
- Cardiovascular risks
Important Disclaimer
The Pyrocaps Capsule 20 mg Capsules professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
